• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19:具有悠久历史、流行病学和迄今进展的全球性挑战。

COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far.

机构信息

Department of Chemistry, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia.

Department of Chemistry, King Fahd University of Petroleum and Minerals, P.O. Box 5048, Dhahran 31261, Saudi Arabia.

出版信息

Molecules. 2020 Dec 23;26(1):39. doi: 10.3390/molecules26010039.

DOI:10.3390/molecules26010039
PMID:33374759
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7795815/
Abstract

Humans have witnessed three deadly pandemics so far in the twenty-first century which are associated with novel coronaviruses: SARS, Middle East respiratory syndrome (MERS), and COVID-19. All of these viruses, which are responsible for causing acute respiratory tract infections (ARTIs), are highly contagious in nature and/or have caused high mortalities. The recently emerged COVID-19 disease is a highly transmittable viral infection caused by another zoonotic novel coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Similar to the other two coronaviruses such as SARS-CoV-1 and MERS-CoV, SARS-CoV-2 is also likely to have originated from bats, which have been serving as established reservoirs for various pathogenic coronaviruses. Although, it is still unknown how SARS-CoV-2 is transmitted from bats to humans, the rapid human-to-human transmission has been confirmed widely. The disease first appeared in Wuhan, China, in December 2019 and quickly spread across the globe, infected 48,539,872 people, and caused 1,232,791 deaths in 215 countries, and the infection is still spreading at the time of manuscript preparation. So far, there is no definite line of treatment which has been approved or vaccine which is available. However, different types of potential vaccines and therapeutics have been evaluated and/or are under clinical trials against COVID-19. In this review, we summarize different types of acute respiratory diseases and briefly discuss earlier outbreaks of coronaviruses and compare their occurrence and pathogenicity with the current COVID-19 pandemic. Various epidemiological aspects of COVID-19 such as mode of spread, death rate, doubling time, etc., have been discussed in detail. Apart from this, different technical issues related to the COVID-19 pandemic including use of masks and other socio-economic problems associated with the pandemic have also been summarized. Additionally, we have reviewed various aspects of patient management strategies including mechanism of action, available diagnostic tools, etc., and also discussed different strategies for the development of effective vaccines and therapeutic combinations to deal with this viral outbreak. Overall, by the inclusion of various references, this review covers, in detail, the most important aspects of the COVID-19 pandemic.

摘要

到目前为止,人类在 21 世纪已经见证了三次与新型冠状病毒相关的致命大流行:非典、中东呼吸综合征(MERS)和 COVID-19。所有这些病毒都导致急性呼吸道感染(ARTIs),在性质上具有高度传染性和/或导致高死亡率。最近出现的 COVID-19 疾病是一种由另一种人畜共患的新型冠状病毒引起的高度传染性病毒感染,这种新型冠状病毒被称为严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)。与 SARS-CoV-1 和 MERS-CoV 等其他两种冠状病毒一样,SARS-CoV-2 也可能源自蝙蝠,蝙蝠一直是各种致病性冠状病毒的既定宿主。尽管目前尚不清楚 SARS-CoV-2 如何从蝙蝠传播到人类,但已经广泛证实了这种病毒可以在人与人之间快速传播。这种疾病于 2019 年 12 月首次在中国武汉出现,随后迅速在全球范围内传播,感染了 48539872 人,并在 215 个国家造成 1232791 人死亡,在撰写本文时,感染仍在继续传播。到目前为止,还没有被批准或可用的明确治疗方法。然而,已经评估了不同类型的潜在疫苗和疗法,并正在针对 COVID-19 进行临床试验。在这篇综述中,我们总结了不同类型的急性呼吸道疾病,并简要讨论了以前的冠状病毒爆发,并将其发生和致病性与当前的 COVID-19 大流行进行了比较。详细讨论了 COVID-19 的各种流行病学方面,如传播方式、死亡率、倍增时间等。除此之外,还总结了与 COVID-19 大流行相关的各种技术问题,包括口罩的使用和大流行带来的其他社会经济问题。此外,我们还审查了患者管理策略的各个方面,包括作用机制、可用诊断工具等,并讨论了开发有效疫苗和治疗组合以应对这种病毒爆发的不同策略。总的来说,通过纳入各种参考文献,本综述详细涵盖了 COVID-19 大流行的最重要方面。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/572a/7795815/8ada9c9a2068/molecules-26-00039-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/572a/7795815/75a6588312c8/molecules-26-00039-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/572a/7795815/3527920cb3e9/molecules-26-00039-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/572a/7795815/f6fc721e2b8f/molecules-26-00039-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/572a/7795815/8ada9c9a2068/molecules-26-00039-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/572a/7795815/75a6588312c8/molecules-26-00039-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/572a/7795815/3527920cb3e9/molecules-26-00039-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/572a/7795815/f6fc721e2b8f/molecules-26-00039-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/572a/7795815/8ada9c9a2068/molecules-26-00039-g004.jpg

相似文献

1
COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far.COVID-19:具有悠久历史、流行病学和迄今进展的全球性挑战。
Molecules. 2020 Dec 23;26(1):39. doi: 10.3390/molecules26010039.
2
The novel zoonotic COVID-19 pandemic: An expected global health concern.新型人畜共患的新冠疫情:一个意料之中的全球卫生问题。
J Infect Dev Ctries. 2020 Mar 31;14(3):254-264. doi: 10.3855/jidc.12671.
3
Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.新型冠状病毒肺炎、严重急性呼吸综合征和中东呼吸综合征的生物学、临床和流行病学特征,以及 ACE2 的 AutoDock 模拟
Infect Dis Poverty. 2020 Jul 20;9(1):99. doi: 10.1186/s40249-020-00691-6.
4
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.SARS-CoV-2 及其他人类致病冠状病毒的抗病毒药物和可用药靶的现状。
Drug Resist Updat. 2020 Dec;53:100721. doi: 10.1016/j.drup.2020.100721. Epub 2020 Aug 26.
5
Human and novel coronavirus infections in children: a review.儿童人感染和新型冠状病毒感染:综述。
Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25.
6
SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic.严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)/COVID-19 及其相关疗法和疫苗的研究进展,以应对这一新兴的大流行病。
Ann Clin Microbiol Antimicrob. 2020 Sep 2;19(1):40. doi: 10.1186/s12941-020-00384-w.
7
HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV.HTCC 作为 SARS-CoV-2 和 MERS-CoV 的聚合抑制剂。
J Virol. 2021 Jan 28;95(4). doi: 10.1128/JVI.01622-20.
8
A Review on Screening Models for Potential Therapeutic Candidates and Targets Against SARS-CoV-2.SARS-CoV-2 潜在治疗候选物和靶点的筛选模型综述
Curr Drug Targets. 2021;22(11):1232-1254. doi: 10.2174/1389450121666201228122845.
9
COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses.新型冠状病毒肺炎感染:人类冠状病毒的起源、传播及特征
J Adv Res. 2020 Mar 16;24:91-98. doi: 10.1016/j.jare.2020.03.005. eCollection 2020 Jul.
10
Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion.阿贝尔森激酶抑制剂是严重急性呼吸综合征冠状病毒和中东呼吸综合征冠状病毒融合的强效抑制剂。
J Virol. 2016 Sep 12;90(19):8924-33. doi: 10.1128/JVI.01429-16. Print 2016 Oct 1.

引用本文的文献

1
Musculoskeletal Complications in COVID-19: Exploring the Role of Key Biomarkers.新型冠状病毒肺炎的肌肉骨骼并发症:探索关键生物标志物的作用
Int J Mol Sci. 2025 Sep 3;26(17):8569. doi: 10.3390/ijms26178569.
2
Prevalence and correlates of depression and anxiety among nursing staff in the post-COVID-19 era: a cross-sectional study from southern Iran.新冠疫情后时代护理人员中抑郁和焦虑的患病率及其相关因素:来自伊朗南部的一项横断面研究
BMC Nurs. 2025 Sep 1;24(1):1148. doi: 10.1186/s12912-025-03810-6.
3
Menstrual Disorders Following Covid 19 Vaccination in Women of Reproductive Age and Post-Menopause. A Systematic Review.

本文引用的文献

1
Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2.设计的蛋白纳米颗粒疫苗引发针对 SARS-CoV-2 的强效中和抗体反应。
Cell. 2020 Nov 25;183(5):1367-1382.e17. doi: 10.1016/j.cell.2020.10.043. Epub 2020 Oct 31.
2
Immunity, endothelial injury and complement-induced coagulopathy in COVID-19.COVID-19 中的免疫、内皮损伤和补体诱导的凝血异常。
Nat Rev Nephrol. 2021 Jan;17(1):46-64. doi: 10.1038/s41581-020-00357-4. Epub 2020 Oct 19.
3
Molecular Architecture of the SARS-CoV-2 Virus.
育龄期及绝经后女性接种新冠病毒疫苗后的月经紊乱。一项系统综述。
Health Sci Rep. 2025 Aug 19;8(8):e71103. doi: 10.1002/hsr2.71103. eCollection 2025 Aug.
4
Advancements in CRISPR-Cas Systems for Genome Editing towards Eradication of Human Microbial Pathogens.用于基因组编辑以根除人类微生物病原体的CRISPR-Cas系统的进展
Mol Biotechnol. 2025 Aug 20. doi: 10.1007/s12033-025-01482-w.
5
SARS-CoV-2 subvariant XEC: emerging challenges amidst the global decline of KP.3.1.1.严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)亚变体XEC:在KP.3.1.1全球流行率下降背景下出现的新挑战
BMC Res Notes. 2025 Jul 24;18(1):322. doi: 10.1186/s13104-025-07371-4.
6
Retinal Detachment Complicating Endogenous Endophthalmitis in a COVID-19 Patient With Superimposed Bacteremia.一名合并菌血症的COVID-19患者发生视网膜脱离并发内源性眼内炎
Case Rep Infect Dis. 2025 Jul 12;2025:8875730. doi: 10.1155/crdi/8875730. eCollection 2025.
7
Comprehensive clinical and metabolomics profiling of COVID-19 Mexican patients across three epidemiological waves.对墨西哥COVID-19患者在三个疫情流行阶段进行的全面临床和代谢组学分析。
Front Mol Biosci. 2025 Jun 18;12:1607583. doi: 10.3389/fmolb.2025.1607583. eCollection 2025.
8
Oxidative stress and antioxidant therapeutics in autism spectrum disorder: a biochemical and structure-activity relationship perspective.自闭症谱系障碍中的氧化应激与抗氧化治疗:生物化学及构效关系视角
Mol Divers. 2025 Jun 30. doi: 10.1007/s11030-025-11274-8.
9
Glycosylated Receptor-Binding-Domain-Targeting Mucosal Vaccines Protect Against SARS-CoV-2 Omicron and MERS-CoV.靶向糖基化受体结合域的黏膜疫苗可预防新冠病毒奥密克戎变异株和中东呼吸综合征冠状病毒。
Vaccines (Basel). 2025 Mar 10;13(3):293. doi: 10.3390/vaccines13030293.
10
Clinical manifestations of Long-COVID: an observational perspective.长新冠的临床表现:一项观察性研究视角
Front Med (Lausanne). 2025 Mar 19;12:1523817. doi: 10.3389/fmed.2025.1523817. eCollection 2025.
SARS-CoV-2 病毒的分子结构。
Cell. 2020 Oct 29;183(3):730-738.e13. doi: 10.1016/j.cell.2020.09.018. Epub 2020 Sep 6.
4
Applications of digital technology in COVID-19 pandemic planning and response.数字技术在 COVID-19 大流行规划和应对中的应用。
Lancet Digit Health. 2020 Aug;2(8):e435-e440. doi: 10.1016/S2589-7500(20)30142-4. Epub 2020 Jun 29.
5
Community Use Of Face Masks And COVID-19: Evidence From A Natural Experiment Of State Mandates In The US.社区使用口罩与 COVID-19:来自美国州政府强制令的自然实验证据。
Health Aff (Millwood). 2020 Aug;39(8):1419-1425. doi: 10.1377/hlthaff.2020.00818. Epub 2020 Jun 16.
6
Spiking Pandemic Potential: Structural and Immunological Aspects of SARS-CoV-2. Spike 大流行潜力:SARS-CoV-2 的结构和免疫学方面。
Trends Microbiol. 2020 Aug;28(8):605-618. doi: 10.1016/j.tim.2020.05.012. Epub 2020 May 20.
7
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.羟氯喹作为 COVID-19 暴露后预防的随机试验。
N Engl J Med. 2020 Aug 6;383(6):517-525. doi: 10.1056/NEJMoa2016638. Epub 2020 Jun 3.
8
SARS-CoV-2 entry in host cells-multiple targets for treatment and prevention.SARS-CoV-2 进入宿主细胞的途径——治疗和预防的多个靶点。
Biochimie. 2020 Aug;175:93-98. doi: 10.1016/j.biochi.2020.05.012. Epub 2020 May 29.
9
Reduction of secondary transmission of SARS-CoV-2 in households by face mask use, disinfection and social distancing: a cohort study in Beijing, China.戴口罩、消毒和社交隔离措施降低家庭中 SARS-CoV-2 的二次传播:中国北京的一项队列研究。
BMJ Glob Health. 2020 May;5(5). doi: 10.1136/bmjgh-2020-002794.
10
15 drugs being tested to treat COVID-19 and how they would work.15种正在进行新冠病毒治疗测试的药物及其作用原理。
Nat Med. 2020 May 15. doi: 10.1038/d41591-020-00019-9.